RAPAFLO 8 MG CAPSULE

silodosin
$8.3953per EA
Discontinued
High Outlier

Strength

8 mg/1

Manufacturer

Allergan, Inc.

NDC

00023614230

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

3/18/2026

Active Ingredients

SILODOSIN

Approval Type

New Drug (NDA)

FDA Application

NDA022206

On Market Since

3/23/2009

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price History

1W

0.0%

1M

0.0%

3M

-0.2%

6M

+0.1%

1Y

-0.1%

3Y

-0.4%

5Y

+0.4%

All

+5.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.